Raymond James & Associates Has $698,000 Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

Raymond James & Associates lifted its stake in Transcat, Inc. (NASDAQ:TRNS) by 6.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,384 shares of the scientific and technical instruments company’s stock after acquiring an additional 387 shares during the quarter. Raymond James & Associates’ holdings in Transcat were worth $698,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of TRNS. State Board of Administration of Florida Retirement System bought a new position in Transcat in the third quarter valued at approximately $207,000. Arizona State Retirement System acquired a new position in Transcat during the third quarter worth $213,000. James Investment Research Inc. bought a new stake in Transcat during the third quarter worth $221,000. Quantbot Technologies LP raised its position in Transcat by 118.2% during the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock worth $232,000 after acquiring an additional 1,284 shares in the last quarter. Finally, Diversified Trust Co lifted its stake in Transcat by 4.3% in the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock valued at $266,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on TRNS. TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Oppenheimer reissued an “outperform” rating and set a $125.00 price target (up previously from $120.00) on shares of Transcat in a research report on Thursday, April 18th. Finally, HC Wainwright restated a “buy” rating and issued a $124.00 price objective on shares of Transcat in a research note on Tuesday, April 16th.

Transcat Price Performance

Shares of TRNS opened at $114.98 on Wednesday. The firm has a market capitalization of $1.02 billion, a PE ratio of 88.45 and a beta of 0.59. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The company’s 50-day moving average is $108.64 and its 200-day moving average is $102.39. Transcat, Inc. has a fifty-two week low of $74.89 and a fifty-two week high of $116.19.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. Transcat had a net margin of 4.16% and a return on equity of 9.32%. The firm had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. Equities analysts forecast that Transcat, Inc. will post 1.34 EPS for the current year.

Insider Buying and Selling

In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $111.30, for a total value of $556,500.00. Following the transaction, the chief executive officer now directly owns 108,478 shares of the company’s stock, valued at approximately $12,073,601.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CEO Lee D. Rudow sold 2,373 shares of the firm’s stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now directly owns 103,688 shares of the company’s stock, valued at $11,553,953.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Lee D. Rudow sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total value of $556,500.00. Following the completion of the sale, the chief executive officer now owns 108,478 shares of the company’s stock, valued at $12,073,601.40. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,073 shares of company stock valued at $900,023. Insiders own 4.20% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.